How will my treatment change if my HS gets worse or stops responding to treatments
Summary: Metabolism boosters carry significant safety concerns, including cardiovascular risks, liver damage, and product contamination, with only modest and temporary metabolic effects
However, researchers haven't tested this unofficial use of Wegovy to the same rigorous standards as the clinical dosing schedule, and it may not be safe
One concern is the lack of conclusive evidence for GLP-1R expression in the liver
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for your individual appetite-regulation profile by analyzing predispositions in GLP1R, GIPR, FTO, and MC4R pathways
These symptoms are typically manageable and don't require stopping the medication